• Researchers have designed a blood test for cancer that looks at the methylation of cell-free DNA.
• A large-scale trial is ongoing to determine how the Gallieri test, as it is known, influences the time to cancer diagnosis.
• Some results from the trial were recently presented at a conference.
• They show a high rate of false positives but a low rate of false negatives.

By Hannah Flynn on September 16, 2022

Fact checked by Ferdinand Lali, Ph.D.

read full article